One in three patients with cancer meets the criteria for mental disorders: what does that mean
Open accessAbstract
ported that 31.8% of patients with cancer met the strict diagnostic criteria for mental disorders. The highest prevalence was found in patients with breast cancer (42%) and patients with head and neck cancer (41%); the lowest prevalence was found in patients with stomach or esophageal cancers (21%) and prostate cancer (22%). From their observation, Mehnert et al 1 (p3540) conclude, “Our findings provide evidence for the strong need for psycho-oncological interventions.” We believe that several issues must be considered before a conclusion about the need for psycho-oncological interventions can be drawn. The first issue is whether mental disorders occur more frequently in patients with cancer than in the general population. A direct comparison between prevalence rates of mental disorders in patients with cancer and in the general population was made in a recent study in 24 countries. 2 The 12-month prevalence rate of anxiety and mood disorders was 18.4% among respondents with active cancer, 14.6% among survivors of cancer, and 13.3% among cancer-free respondents in all countries combined. 2 A similar pattern emerged in separate analyses of patients in high-income and low- to middle-income countries. Investigators from two recent studies reported an increased incidence of mental disorders after the diagnosis of breast cancer compared with rates in the general population. 3,4 On the basis of the data presented in these papers, we calculated the proportion of anxiety and mood disorders attributable to the diagnosis of cancer (Table 1). These calculations showed that approximately 20% to 25% of anxiety and mood disorders are attributable to the diagnosis of breast cancer. We concluded that the incidence and prevalence of mental disorders is indeed higher in patients with cancer than in the general population. A second issue to consider is whether patients perceive their emotional concerns as a need for mental health treatment. In a USbased study, 5 8.3% of patients who survived cancer reported a mental health visit in the past 12 months. Another 2.5% had an unmet need for mental health services, which was defined as a report of psychological distress and no report of a mental health visit in the past 12 months. Thus, 10.8% of survivors of cancer had a need for mental health care. In individuals with cancer and other chronic disease, the percentages of patients who reported a mental health visit in the past 12 months and who had unmet needs for mental health services were 9.6% and 3.0%, respectively—a total of 12.6% of all patients (data were obtained in 2010). 5 In a qualitative study of patients with hematologic malignancies who were undergoing autologous stem-cell transplantation, 6 emotional concerns were perceived as problems only if they interfered with a desirable goal in life. If the issues did not interfere with such a goal, patients often accepted their emotional concerns. It seems that meeting the criteria for a mental disorder does not necessarily imply the subjective need for treatment. Even when patients face a life-threatening disease and burdensome treatment, they seem to manage by themselves with help from their families and friends and with help from oncologists and nurses. These patients should not automatically be considered in need of formal mental health care, although they may benefit from other types of support, such as peer and self-management supports. Obviously, specific patients may have a true need for mental health care, and formal care
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Breast cancer patients had a greater rate of mental disorders after diagnosis than the general population, with 42% meeting rigorous diagnostic criteria for mental disorders within four weeks of diagnosis, the highest rate of all cancers.
“Breast cancer patients had a greater rate of mental disorders after diagnosis than the general population, with 42% meeting rigorous diagnostic criteria for mental disorders within four weeks of diagnosis, the highest rate of all cancers [5].”
From Effectiveness of Acceptance and Commitment Therapy (ACT) on disease acceptance for breast cancer patients: Study protocol of a randomized controlled trial (2024) · cites this paper as [5]
The opening discussion (p. 1) reports that breast cancer patients had the highest prevalence of mental disorders (42%) under strict diagnostic criteria, and it reports increased incidence after breast cancer diagnosis compared with the general population. The References (p. 2) identify the underlying measure as four-week prevalence; the copy does not say the 42% met criteria within four weeks *of diagnosis*. (LLM, conf=0.89)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0086 · Cited by 649 · see citing works
Sharpe, M., Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., & Murray, G. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61231-9 · Cited by 269 · see citing works
Galway, K., Black, A., Cantwell, M. M., Cardwell, C. R., Mills, M. E., & Donnelly, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007064.pub2 · Cited by 220 · see citing works
Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., Murray, G., & Sharpe, M. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70343-2 · Cited by 155 · see citing works
Nakash, O., Levav, I., Aguilar-Gaxiola, S., Alonso, J., Andrade, L. H., Angermeyer, M. C., Bruffaerts, R., Caldas-de-Almeida, J. M., Florescu, S., de Girolamo, G., et al. (2014) · Psycho-Oncology · doi:10.1002/pon.3372 · Cited by 117 · see citing works
Suppli, N. P., Johansen, C., Christensen, J., Kessing, L. V., Kroman, N. T., & Dalton, S. O. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0419 · Cited by 116 · see citing works
Treatment of depression in adults with cancer: a systematic review of randomized controlled trials
Walker, J., Sawhney, A., Hansen, C., Ahmed, S., Martin, P., Symeonides, S., Murray, G., & Sharpe, M. (2013) · Psychological Medicine · doi:10.1017/s0033291713001372 · Cited by 66 · see citing works
Hung, Y.-P., Liu, C.-J., Tsai, C.-F., Hung, M.-H., Tzeng, C., Liu, C.-Y., & Chen, T.-J. (2013) · Psycho-Oncology · doi:10.1002/pon.3277 · Cited by 52 · see citing works
Whitney, R. L., Bell, J. F., Bold, R. J., & Joseph, J. G. (2014) · Psycho-Oncology · doi:10.1002/pon.3569 · Cited by 25 · see citing works
Braamse, A. M. J. (2015) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 12 · see citing works
Self-citationThekdi, S. M. (2015) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2015.04.010 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Song, W., Shari, N. I., Song, J., Zhang, R., Mansor, N. S., Leong Bin Abdullah, M. F. I., & Zhang, Z. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312669 · Cited by 9 · see citing works
- Authors
- Dekker, J., Braamse, A., van Linde, M. E., Voogd, A. C., Beekman, A., & Verheul, H. M.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- VU Medical Center, Amsterdam, the Netherlands
- Maastricht University (NL)
- Venue
- Journal of Clinical Oncology
- Published
- 2015-09-01
- Volume
- 33
- Issue
- 25
- Pages
- 2826-2828
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2151621955
- Cited by
- 15
- References
- 11
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2017: 2 · 2016: 2 · 2015: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- VU Research Portal (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
- Keywords
- cancer, mental illness, anxiety disorders, mood disorders, psycho-oncology, unmet mental health needs, breast cancer, head and neck cancer, cancer survivors, prevalence of mental disorders, psychological distress, help-seeking, chronic disease, mental health service utilization, quality of life, quality of life interventions
- MeSH terms
- Mental Disorders, Female, Humans, Male, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review